Related Experiment Video
Updated: May 7, 2026

Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
Published on: February 3, 2014
Mavacamten in Right Ventricular Outflow Tract Obstruction
Jasmine K Malhi1, Richard T Carrick1, Chloe Duvall1
1Johns Hopkins University School of Medicine, Department of Medicine, Division of Cardiology, Baltimore, Maryland, USA.
Mavacamten successfully treated severe right ventricular outflow tract (RVOT) obstruction in a hypertrophic cardiomyopathy (HCM) patient. This offers a new therapeutic option for this rare but serious complication.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertrophic cardiomyopathy (HCM) can lead to ventricular hypertrophy.
- Right ventricular outflow tract (RVOT) obstruction is a rare but significant complication in HCM patients.
Observation:
- This study details an unusual case of severe RVOT obstruction in an HCM patient.
- The patient presented with significant symptoms attributed to the obstruction.
Findings:
- Successful relief of severe RVOT obstruction was achieved using mavacamten.
- Mavacamten demonstrated efficacy in managing this specific HCM complication.
Implications:
- Mavacamten may represent a novel therapeutic strategy for RVOT obstruction in HCM.
- Further research is warranted to explore mavacamten's role in managing HCM-related complications.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy